BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Diabetes mellitus
,
Adipose tissue
,
rs2230926
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Myeloma
(phenotype)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
IGHD
CCND1
IGL
IGLV1-44
IGLJ3
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_BRCA1_PCC_NETWORK
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP
heterocycle metabolic process
PUJANA_CHEK2_PCC_NETWORK
heterocyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Plasma cell tumor progression
Differences in TC molecular subtypes of multiple myeloma
Pre-osteocyte HOB-01 cells co-cultured with myeloma JJN3 cells
Multiple myeloma cells treated with A2A and Beta-2 Adrenergic Receptor agonists with dexamethasone
Resistance to RNA-directed nucleoside analogues in B-Cell neoplasms
Explore Curated Studies Results
Literature
Most Relevant Literature
Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma pa…
Application of MRI Water-Fat Separation Technology in Patients with Multiple Myeloma].
How I treat relapsed multiple myeloma.
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: eme…
Daratumumab: Beyond Multiple Myeloma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Multiple Myeloma
CTFEA Myeloma Study
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
Machine Learning in Myeloma Response
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ